ENDRA Life Sciences (NDRA) Non-cash Items (2021 - 2026)

ENDRA Life Sciences has disclosed Non-cash Items across 6 years of filings, most recently posting $184.0 for Q1 2026.

• In Q1 2026, Non-cash Items fell 22.03% year-over-year to $184.0; the TTM figure through Mar 2026 stood at $184.0 (down 22.03% YoY), while the FY2025 annual figure was $216.0, up 16.76% from the prior year.
• Non-cash Items slipped to $184.0 in Q1 2026, from $216.0 in the prior quarter.
• Over the last five years, Non-cash Items for NDRA reached as high as $3.1 million in Q3 2022 and fell as low as $184.0 in Q1 2026.
• The 5-year median for Non-cash Items is $234763.0 (2023), against an average of $648871.3.
• Annual changes were most pronounced in 2024 — Non-cash Items jumped 71.31% — and 2025, when it slumped 99.95%.
• A 5-year view of Non-cash Items shows it stood at $180742.0 in 2022, then surged by 48.97% to $269255.0 in 2023, then tumbled by 99.93% to $185.0 in 2024, then grew by 16.76% to $216.0 in 2025, then slipped by 14.81% to $184.0 in 2026.
• According to Business Quant data, Non-cash Items over the past three periods registered $184.0, $216.0, and $229.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.